Global Bioinformatics Services Market Size Study, By Type (NGS, Chemoinformatics, Microarray Data Analysis, Biological Data Curation), By Application (Genomics, Proteomics, Metabolomics, Drug Discovery), By Sector (Medical, Animal, Agricultural, Academics

The global bioinformatics services market was valued at approximately USD 2.8 billion in 2023 and is anticipated to witness a robust CAGR of 14.46% from 2024 to 2032. With the rising adoption of next-generation sequencing (NGS), artificial intelligence (AI), and machine learning (ML) algorithms, bioinformatics is revolutionizing multiple industries, including pharmaceuticals, biotechnology, and clinical research. The growing demand for personalized medicine, drug discovery, and genomics research has significantly fueled investments in bioinformatics services, making it an indispensable tool for genetic data analysis and molecular modeling.

The integration of AI-driven bioinformatics platforms has transformed how data is processed, analyzed, and interpreted in medical research and precision medicine. Cloud-based bioinformatics services have further propelled market growth by offering scalable, flexible, and cost-efficient solutions for large-scale genomic data analysis. The rising prevalence of chronic diseases such as cancer and cardiovascular disorders has also led to an increased demand for bioinformatics-driven drug discovery, enhancing the industry's expansion. Additionally, government-backed initiatives in genomics, combined with strategic collaborations between biotech firms, pharmaceutical companies, and research institutions, continue to strengthen the market's global presence.

The expansion of bioinformatics services in emerging markets such as Asia Pacific, Latin America, and the Middle East & Africa is accelerating due to rising genomics investments and biotech advancements. Countries such as China, India, and Japan are heavily investing in biotechnology, supported by government funding and research initiatives. Meanwhile, North America remains a dominant player, with leading bioinformatics firms, research institutions, and pharmaceutical giants leveraging bioinformatics tools for advanced drug discovery, precision medicine, and agricultural genomics.

Major market players included in this report are:
• Agilent Technologies, Inc.
• BGI Group
• Dotmatics
• Labvantage - Biomax GmbH
• CD Genomics
• Creative Biolabs
• DNAnexus, Inc.
• DNASTAR
• Fios Genomics
• Illumina, Inc.
• PerkinElmer Inc.
• QIAGEN
• Thermo Fisher Scientific Inc.
• SOPHiA GENETICS
• Strand Life Sciences

The detailed segments and sub-segments of the market are explained below:

By Type
• Next-Generation Sequencing (NGS)
Targeted Sequencing Analysis
Transcriptome Analysis
Whole Genome
Chip Seq Analysis
De novo Assembly
Methyl Seq Analysis
• Chemoinformatics
Sequence Analysis Platforms
Molecular Modeling
Docking
Clinical Trial Data Management
Others
• Microarray Data Analysis
• Biological Data Curation
• Scientific Software Testing
• Other Services

By Application
• Genomics
• Transcriptomics
• Proteomics
• Metabolomics
• Drug Discovery
• Others

By Sector
• Medical
• Animal
• Agricultural
• Academics

By Region

North America
• U.S.
• Canada
• Mexico

Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway

Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Thailand

Latin America
• Brazil
• Argentina

Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Years considered for the study:
• Historical Year: 2022
• Base Year: 2023
• Forecast Period: 2024-2032

Key Takeaways:
• Market estimates and forecasts for 10 years (2022-2032).
• Annualized revenues and regional-level analysis for each market segment.
• Detailed competitive landscape analysis.
• Insights into key industry trends and future market opportunities.
• Demand-side and supply-side analysis of the bioinformatics services market.
• Coverage of regulatory frameworks, data security standards, and privacy laws affecting the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.